It can be difficult in normal times to get reliable, timely information from many long-term care facilities without filing FOIAs or diving deep into inspection reports. During this COVID-19 pandemic, it can be nearly impossible. So when Kaiser Health News’ Rachana Pradhan wanted to learn whether, and how, nursing homes were conducting all-important testing of residents and staff, it’s not surprising she ran into a few roadblocks. Continue reading
Six months after the first nursing home residents died of the novel coronavirus, many nursing homes and long-term care facilities continue to face a shortage of personal protective equipment, test kits, delayed test results and worker shortages. At the same time, positivity rates continue to climb in many states and, once again, nursing homes are among the leading sources of death and infections nationwide.
The COVID-19 Nursing Home Data tracker of the federal Centers for Medicare and Medicaid Services (CMS), reports more than 164,055 residents have confirmed cases of the virus and more than 102,531 have suspected cases as of July 26, according to the most recently available data. Continue reading
Cities, counties and states around the country are probably on heightened alert for unauthorized pop-up COVID-19 testing operations after San Diego County took steps to shut down one such clinic Wednesday, lest a bogus test give someone a false result and jeopardize public health.
As the number of SARS-CoV-2 infections and deaths due to the COVID-19 disease increase daily nationwide, journalists are asking why the United States lags so far behind other countries in introducing clinical laboratory tests for the virus that causes the illness.
Some strong examples of such coverage in the last few days include “11 to 100,000: What went wrong with coronavirus testing in the U.S.?,” by Meg Kelly, Sarah Cahlan and Elyse Samuels at The Washington Post on March 30, and “The Lost Month: How a Failure to Test Blinded the U.S. to Covid-19,” by Michael D. Shear, Abby Goodnough, Sheila Kaplan, Sheri Fink, Katie Thoma s and Noah Weiland at The New York Times on March 28. Continue reading
The just-passed multibillion-dollar Families First Coronavirus Response Act includes free diagnostic testing for the new COVID-19 illness — for those fortunate enough to get a test if needed. The law also includes paid sick leave, nutrition assistance and boosts unemployment benefits for Americans out of work due to the pandemic, as Barbara Sprunt reported for NPR.
President Trump signed the bill into law after the U.S. Senate passed it on Wednesday. The House of Representatives had approved it the previous week. Continue reading
In December 2016, Charles Piller (@cpiller), the west coast editor for Stat, reported that a genetic test to identify patients who could be prone to addiction lacked a firm scientific basis.
With an eye-opening headline, “Called ‘hogwash,’ a gene test for addiction risk exploits opioid fears,” the article raised important questions about the Proove Opioid Risk test from Proove Biosciences in Irvine, Calif. Continue reading